Typical Cycle Lengths Mild to moderate injury (tendon, ligament, muscle): 24 weeks at 250500mcg per day Severe or post-operative injuries: 46 weeks, sometimes extending to 8 weeks Gastrointestinal issues (ulcers, IBS): 46 weeks at 250500mcg per day, oral or subQ Neurological repair or systemic inflammation: 46 weeks, systemic dosing recommended For most users, results begin to show within the first 710 days , especially in soft tissue or gut repair cases
Always test formulation stability and mucosal response parameters
Signs include feeling very tired, weak, and having nerve problems
Future Therapeutic Targets in Rheumatoid Arthritis
In the gastrointestinal tract, BPC-157 accelerates epithelial regeneration, protects the gastric mucosa, and promotes healing of ulcers through enhanced mucosal blood flow and growth factor activity